Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2025
Shear Stress Targeted Delivery of Nitroglycerin to Brain Collaterals Improves Ischaemic Stroke OutcomeMagdalena Litman, Sara Azarpeykan, Rebecca J Hood, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 29, 2013
The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trialAtte Meretoja, Leonid Churilov, Bruce C V Campbell, et al.
Neurology|September 2, 2025
Mortality After Cerebral Venous ThrombosisElisa Häppölä, Sini Hiltunen, Erik Lindgren, et al.
Restorative Neurology and Neuroscience|January 7, 2017
Recent progress in translational research on neurovascular and neurodegenerative disordersHans-Ulrich Demuth, Rick M Dijkhuizen, Tracy D Farr, et al.
Stroke|November 23, 2022
Ultra-Long Transfers for Endovascular Thrombectomy-Mission Impossible?: The Australia-New Zealand ExperienceCarlos Garcia-Esperon, Teddy Y Wu, Vinicius Carraro do Nascimento, et al.
The Lancet. Neurology|October 31, 2020
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trialAtte Meretoja, Nawaf Yassi, Teddy Y Wu, et al.
Stroke|June 2, 2026
Diagnostic Yield of Cardiac CT to Detect Cardiac Thrombi in Patients With Acute Ischemic Stroke (AIS of HEARTS)Shan Sui Nio, Daniel S Green, Alexander Berry-Noronha, et al.
Stroke|July 22, 2026
Tenecteplase Efficacy in Patients With Distal Occlusions: Secondary Analysis of the TASTE Randomized Clinical TrialVignan Yogendrakumar, Justin Phung, Hannah Johns, et al.
The Lancet. Neurology|June 16, 2024
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark W Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
Pageof 16